🦊/Investors

Scientia VenturesFull Portfolio

27 tracked investments · listed companies and verified rows first

ADC Therapeutics SAadctherapeutics.cominNYSE: ADCT

ADC Therapeutics is a biopharmaceutical company that develops antibody drug conjugates and other therapies focused on hematology and oncology.

BiotechHealthtechMedical Devices

Ameet Mallik(Chief Executive Officer)inJose Carmona(Chief Financial Officer)Mohamed Zaki(Chief Medical Officer)inKristen Harrington-Smith(Chief Commercial Officer)inDavid Ege(Chief Technical Officer)inPeter Graham(Chief Legal Officer)in

Co-investorsETCapitalHEALTHCARE ROYALTY PARTNERS

Royalty Pharmaroyaltypharma.cominNASDAQ: RPRX

Royalty Pharma acquires and manages pharmaceutical royalties from approved drugs and therapies, providing investors exposure to the biopharma sector without early-stage development risk.

BiotechFintechNew York, US

Pablo Legorreta(Chairman and CEO)in

Co-investorsPaladin Capital Group

Rose Pharmarosepharmainc.com✓ verified

Rose Pharma is a pharmaceutical company developing therapies in gastroenterology and metabolic disorders.

BiotechHealthtechMedical Devices

Enda Kenny(CEO)inLynn Sullivan(Chief Business Officer)in

Co-investorsRosetta Capital Ltd.

Cibuscibus.cominAug 2014

Cibus develops crops using a proprietary gene-editing technology that reproduces nature's own genetic blueprints to add specific traits, such as resistance to heat, pests, fungus, and weeds.

AgTechBiotechClimate TechSan Diego, US

Peter Beetham(Chief Executive Officer)inRory Riggs(Chairman of the Board)Keith Walker, Ph.D.(President)LaDon Johnson(Executive Officer)in

BoardAlain Pompidou(Director)

Board seatMark FinnRory Riggs· per SEC Form D

eReceivablesereceivables.coAug 2014

eReceivables is a healthcare revenue recovery firm that specializes in identifying and resolving underpaid, denied, and overlooked insurance claims for hospitals and healthcare systems.

Enterprise SoftwareFintechHealthtechSaaSHollywood, US

William Whitaker(Chief Operating Officer)Gil Perry(Executive Officer)Steven Griffin(President)

BoardBarbara Rohan(Director)

Board seatRory RiggsJonathan Finn· per SEC Form D

19101910.aiin𝕏

1910 develops an AI platform that integrates multimodal data, frontier AI models, and high-throughput lab automation to accelerate drug discovery and development for pharmaceutical companies.

AI & Machine LearningBiotechDeep TechHealthtechBoston, US

Jen Asher(Founder & CEO)in

Co-investorsY CombinatorFoundersX VenturesPlayground Global

ConnectureDRXconnecture.comin𝕏

ConnectureDRX provides Medicare enrollment and drug transparency technology for health plans, agents, and consumers.

Data & InfrastructureHealthtechInsurTechSaaSBrookfield, US

Lea DeVillers(Executive Officer)inDavid A. Sockel(Executive Officer)inJeffrey A. Surges(Executive Officer, Director)Mark E. Granville(Executive Officer)James P. Purko(Executive Officer)inRobert Douglas Schneider(Executive Officer)

Co-investorsAtlanta Technology AngelsChrysalis Ventures

Cristcotcristcot.comin

Cristcot is a pharmaceutical development and medical device company focused on drug formulations, device engineering, and clinical development.

BiotechDeep TechHealthtechMedical DevicesAustin, US

Jennifer J. Davagian(Founder/Chief Executive Officer)inMark C. Ensign(Founder/Chief Operating Officer/Chief Scientific Officer)in

Fibrogenfibrogen.comin𝕏Nov 2014

Kyntra Bio (formerly FibroGen) is a clinical-stage biopharmaceutical company developing therapies for oncology and rare diseases, including serious and life-threatening conditions.

BiotechHealthtechSan Francisco, US

Thomas B. Neff(Executive Officer, Director)Frank H. Valone(Executive Officer)inK. Peony Yu(Executive Officer)inPat Cotroneo(Executive Officer)in

BoardRory B. Riggs(Director)Kalevi Kurkijarvi(Director)

Co-investorsAvalon BioVenturesRidgeback CapitalMaverick Ventures

Fund Imissionbaycapital.comin

Mission Bay Capital is an early-stage investment firm dedicated to funding and supporting entrepreneur-scientists building companies to address chronic diseases and environmental challenges.

BiotechDeep TechFintechImpact & Social GoodSan Francisco, US

BoardDouglas Crawford(Managing General Partner)Peter D. Parker(Venture Partner)

Co-investorsAndreessen HorowitzavraBONDBritish International InvestmentCapitalGDurable Capital Partners+10 more

Fund II (Select)bpcruk.com

BioPharma Credit is an investment fund that generates returns through debt financing secured by royalties and cash flows from life sciences product sales.

Fintech

Fund IIIx-vax.com

X-vax Legend sells "Nagapetir" branded decorative stickers with various designs for use on motorcycles, cars, laptops, helmets, and community or brand promotion.

E-commerce

Co-investorsAdjuvant Capital

Humanityhumanity.healthin𝕏

Humanity offers an enterprise employee wellness platform that uses biological age monitoring to help teams improve health and productivity.

Digital HealthHealthtechHR TechLongevityWellness & Fitness

Peter Ward(Founder)in

Co-investorsOne Way VenturesAndreessen HorowitzDeerfield Management CompanyJump CryptoJumpstart NovaPantera Capital+1 more

IntelinAir | AGMRIintelinair.comin𝕏Jan 2015

Intelinair provides aerial imagery and agronomic analytics through its AGMRI platform, delivering in-season alerts and postseason reporting on crop health, weeds, nitrogen deficiency, stand assessment, and yield loss.

AgTechAI & Machine LearningSaaSSan Jose, US

Naira Hovakimyan(Chief Scientific Officer and Secretary)inAl Eisaian(Founder)in

Co-investorsGranatus VenturesHyde Park Venture Partners

Intracellular Therapiesintracellulartherapies.comin

A biopharmaceutical company developing treatments for psychiatric and neurologic disorders based on research into how therapies affect cellular mechanisms.

BiotechDigital HealthHealthtechMedical Devices

Paul Greengard

MarketMusemarketmuse.comin𝕏Series A · Mar 2020 · $3M

MarketMuse provides AI-powered content strategy and research tools for SEO and content teams, enabling them to analyze content inventories at scale, generate optimized briefs, and plan content strategy around user intent and search requirements.

AI & Machine LearningMarketing TechSaaS

Aki BaloghinJeff Coyle(Co-Founder & Chief Revenue Officer)in

Co-investorsAlpine MeridianColle Capital PartnersLaunchCapitalLunaCap VenturesRevUp CapitalRiverside Acceleration Capital+4 more

Payeasenetpayeasenet.com

PayEase operates a payment platform offering internet payments, mobile payments, cross-border payments, foreign card acquiring, and foreign-trade collections for businesses.

FintechSaaS

Pharmaronpharmaron.comin𝕏

Pharmaron is a contract research and manufacturing organization providing drug development and manufacturing services to pharmaceutical and biotech companies.

BiotechDeep TechHealthtechMedical DevicesBeijing, CN

Boliang Lou(Chairman & CEO)in

Co-investorsAisling CapitalDCM VenturesDCMLegend Capital

Sprout Pharmaceuticalssproutpharmaceuticals.com

Sprout Pharmaceuticals is a pharmaceutical company focused on women's sexual health, known for developing Addyi (flibanserin), the first FDA-approved treatment for low libido in women.

BiotechFemTechHealthtechRaleigh, US

Robert S. Whitehead(Director, Executive Director)Cindy Eckert(Founder)Cynthia Whitehead(Chief Commercial Officer)Anne Tomalin(Vice President, Global Regulatory Affairs)Matthew Petzold(Chief Financial Officer and Treasurer)Douglas Eckert(Director, Secretary)

VERIGRAFTverigraft.comin

Verigraft develops personalized tissue-engineered products for severe diseases, including vascular grafts, nerve grafts, and heart valves, targeting regenerative medicine markets globally.

BiotechDeep TechHealthtechMedical Devices

Petter Björquist(Chief Executive Officer)inRaimund Strehl(Chief Technology Officer)inEdvard Nordfors(Chief Financial Officer)in

Co-investorsCapital Cell

Whtwht.care

WHT provides a technology platform designed for private and protected intentional communities that enhances member connections and care support while maintaining human-centered communication.

Digital HealthHealthtechSaaSCharlottesville, US

Rebecca Dillingham(Co-founder)Karen Ingersoll(Co-founder)

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

GenenewsAuven TherapeuticsEnterinTransparency Life Sciences

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.